Skip to content
2000
Volume 16, Issue 1
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Cervical cancer is the third most common cancer among women worldwide and is responsible for 275.000 deaths each year. The development of cervical cancer has been linked to cell cycle disturbances caused by persistent expression of high- risk HPV oncoproteins (E5, E6 and E7), which modulate the expression of host genes and cellular microRNAs. An estimated 5 million women throughout the world are currently infected by HPV and several of them will develop invasive cervical cancer. Despite failures in conventional screening tests, approved therapies have no direct effect on HPV infection. In view of this, effective therapy for cervical cancer is still urgently needed, particularly in developing countries where more than 85% of fatal cases occur. In this paper we review the current molecular targeted therapies which are being explored and may have a significant impact on the treatment of HPV- related cervical dysplasia and carcinoma.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/1389450116666141205150942
2015-01-01
2025-05-07
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/1389450116666141205150942
Loading

  • Article Type:
    Research Article
Keyword(s): Cervical cancer; HPV; microRNA; molecular targets; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test